FindMyKOL
Clinical trialNCT00848393CompletedPhase 2Interventional

Measures to Lower the Stress Response in Pediatric Cardiac Surgery

NCT00848393 is a phase 2 interventional trial sponsored by Nationwide Children's Hospital. As of 18 Nov 2026, it is completed. It studies Fentanyl and Fentanyl + Dexmedetomidine in Atrioventricular Septal Defects (AVSD), Tetralogy of Fallot (TOF) and 1 more condition. The registry lists an enrollment of 52 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2008 and a primary completion date of 31 Dec 2013.

SponsorNationwide Children's Hospital →Enrollment52Atrioventricular Septal Defects (AVSD)Tetralogy of Fallot (TOF)Ventricular Septal Defects (VSD)
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00848393
FieldValue
Registry IDNCT00848393
StatusCompleted
PhasePhase 2
Study typeInterventional trial
Lead sponsorNationwide Children's Hospital
Enrollment52
Registered sites1
Countries1
ConditionsAtrioventricular Septal Defects (AVSD), Tetralogy of Fallot (TOF) and Ventricular Septal Defects (VSD)
DrugsFentanyl and Fentanyl + Dexmedetomidine
Start30 Nov 2008
Primary completion31 Dec 2013
Study completion31 Dec 2013
Last update posted27 Jul 2018

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Cardiac surgery induces a measurable stress response in patients which leads to increased morbidity and mortality post-operatively. Through clinical observation, anesthesiologists have determined that varying the combinations of anesthesia drugs used during surgery and just after reduces the stress response, and by extension, morbidity and mortality. However, only a few studies have explored this phenomenon scientifically.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • Nationwide Children's Hospital

    Columbus

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fentanyl →Fentanyl + Dexmedetomidine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT00848393

Each answer restates registry values shown on this page.

What is NCT00848393?

NCT00848393 is a phase 2 interventional trial sponsored by Nationwide Children's Hospital. It studies Fentanyl and Fentanyl + Dexmedetomidine in Atrioventricular Septal Defects (AVSD), Tetralogy of Fallot (TOF) and 1 more condition.

Who leads NCT00848393?

The registry names Aymen N Naguib, MD (principal investigator, Nationwide Children's Hospital) as the overall official.

Where does NCT00848393 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT00848393 study?

The registered drug and biological interventions are Fentanyl and Fentanyl + Dexmedetomidine.

When did NCT00848393 end?

The registry lists a primary completion date of 31 Dec 2013 and a study completion date of 31 Dec 2013. The sponsor last updated the record on 27 Jul 2018.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.